Zota Health Care (Small Cap - Potential Multibagger) Share Target 2025, 2026 To 2035
|
Zota Health Care Limited |
|||
|
Price: ₹1,015.00 (+2.97%) | ||
| 52 Week Low: ₹440.10 52 Week High: ₹1,060.00 |
|||
| Market Capital: 1,175.74 Crore (Smallcap) | |||
| Healthcare -> Biotechnology | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Zota Health Care Share Price Target For 2025
- 1.1.1: Zota Health Care Share Price Target Table For 2025
- 1.1.2: Short-Term Technical Outlook
- 1.2: Zota Health Care Share Price Target For 2026
- 1.2.1: Zota Health Care Share Price Target Table For 2026
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Zota Health Care Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
- 3: Zota Health Care Brief Company Overview
- 4: Zota Health Care Financial Performance
- 4.0.1: Is Zota Health Care A Good Buy For Long Term?
Zota Health Care, a Small Cap company in the Biotechnology Industry has delivered 469.0% returns in 5-year showing 34.2% quarterly revenue growth, making it a potential Multibagger.
To predict the Zota Health Care's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Zota Health Care Share Price Target For 2025
The line chart displays the monthly closing prices of Zota Health Care with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Zota Health Care shares in 2025, see the table below.
Zota Health Care Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 1206.46 (+18.86%) | Fibonacci Extension Level 123.60% |
| 2025 Target 2 | 1173.07 (+15.57%) | Price Action: Chart |
| 2025 Target 1 | 1161.46 (+14.42%) | Fibonacci Extension Level 23.60% |
| Current Price | 1015.00 | Zota Health Care's share price as of 21 Jan 2025 |
| Stop Loss 1 | 960.0 (-5.42%) | Price Action: 09 Jan 2025 Low |
| Stop Loss 2 | 941.45 (-7.25%) | Price Action: 08 Jan 2025 Low |
| Stop Loss 3 | 919.5 (-9.41%) | Price Action: 14 Jan 2025 Low |
Short-Term Technical Outlook
Current Technical Position: Zota Health Care is showing bullish momentum with price above both 25-day and 50-day moving averages.
Key Technical Level: The 25-day moving average at ₹887.61 serves as the nearest technical reference point.
Historical Returns: 3-month: +68.06% | 6-month: +67.97% | 1-year: +100.46%
Zota Health Care Share Price Target For 2026
The line chart displays the monthly closing prices of Zota Health Care with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Zota Health Care shares in 2026, see the table below.
Zota Health Care Share Price Target Table For 2026
| Level | Value | Analysis |
|---|---|---|
| 2026 Target 3 | 1573.05 (+54.98%) | Price Action: Chart |
| 2026 Target 2 | 1543.72 (+52.09%) | Price Action: Chart |
| 2026 Target 1 | 1528.44 (+50.58%) | Fibonacci Extension Level 64.90% |
| Current Price | 1015.00 | Zota Health Care's share price as of 21 Jan 2025 |
| Stop Loss 1 | 875.3 (-13.77%) | Price Action: 07 Jan 2025 Low |
| Stop Loss 2 | 859.0 (-15.37%) | Price Action: 24 Dec 2024 High |
| Stop Loss 3 | 847.0 (-16.55%) | Price Action: 27 Dec 2024 High |
Long-Term Technical Outlook
52-Week Range Analysis: Zota Health Care is currently trading near its 52-week high of ₹1060, showing strong yearly momentum.
Long-Term Trend Analysis: The stock is maintaining a bullish long-term trend, trading above both 150-day and 250-day moving averages.
Long-Term Performance: 1-year: +100.46% | 3-year: +158.12% | 5-year: +469.01%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Zota Health Care Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹1,015.00 | ||
| 2025 | ₹1,094.65 | +7.84% | ₹1,111.07 |
| 2026 | ₹1,629.75 | +48.88% | ₹1,654.20 |
| 2027 | ₹2,261.76 | +38.77% | ₹2,295.69 |
| 2028 | ₹2,873.72 | +27.05% | ₹2,916.83 |
| 2029 | ₹4,154.92 | +44.58% | ₹4,217.24 |
| 2030 | ₹5,975.45 | +43.81% | ₹6,065.08 |
| 2031 | ₹8,403.42 | +40.63% | ₹8,529.47 |
| 2032 | ₹11,231.54 | +33.65% | ₹11,400.01 |
| 2033 | ₹15,485.35 | +37.87% | ₹15,717.63 |
| 2034 | ₹20,347.14 | +31.39% | ₹20,652.35 |
| 2035 | ₹25,825.12 | +26.92% | ₹26,212.50 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Zota Health Care Brief Company Overview
Zota Health Care Limited: A Leading Healthcare Enterprise Zota Health Care Limited, established in 1995, is a reputable pharmaceutical company headquartered in Surat, India. The company has a strong presence in both the domestic and international markets. Zota offers a diverse...
range of products, including: Generic drugs Over-the-counter products Ayurvedic products Nutraceutical products They specialize in providing medicines for chronic illnesses such as diabetes, heart conditions, and thyroid disorders. Zota is committed to providing affordable and accessible healthcare solutions to its customers. The company operates its retail stores under the DAVAINDA name and exports its products to approximately 30 countries worldwide.Zota Health Care Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 1,175.74 Crore | Market valuation of Zota Health Care's shares. |
| Revenue (TTM) | 168.49 Crore | Total revenue generated by Zota Health Care over the past twelve months. |
| Net Income (TTM) | -10.06 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | -3.73% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | -5.98% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+34.2% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio |
49.41 | Company's total debt divided by total shareholder equity. |
| Total Debt | 50.44 Crore | Sum of Zota Health Care's current & long-term financial obligations. |
| Total Cash | 1.81 Crore | Total amount of liquid funds available to Zota Health Care. |
| Beta | 0.62 | Beta is less than 1 indicating that the Zota Health Care's price is less volatile than the market. |
Is Zota Health Care A Good Buy For Long Term?
Zota Health Care's recent financial performance has been mixed, with revenue growth but a net loss. Its debt and low cash balance raise concerns, but its strong long-term returns indicate potential for growth. As a small-cap stock, it comes with higher risk, but its past performance suggests it could be worth considering for long-term investors with a high-risk tolerance and a diversified portfolio.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
